ObamaCare, tried in Greece, 'leads to bankruptcy, rioting and bloodshed'

8 June 2010

Some people learn from others' mistakes, and some have to "learn the hard way." Will America follow the lead of countries who have actually tried their own version of ObamaCare, or could we still learn from their mistakes? asks Alieta Eck, a New Jersey, USA, physician who has been in private practice in Piscataway since 1988 and involved in health care reform since residency.

In a remarkable statement, the International Monetary Fund has recommended that, before any bailouts are considered, the Greek government must privatize transportation, energy and health care to rein in costs, notes Dr Eck, pointing out that the IMF recognizes that increased government involvement in health care does not save money. It also does not lead to better health care.

In 1983, when the socialists were in power, Greece established "health care for all." Today government spending is unsustainable and Greece is awash in red ink. Talks of budget cuts and program cutbacks are causing rioting and bloodshed, she states.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical